Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kendra Sweet

Showing results (41-50 of 82) with videos related to

Pageof 9
Sort By:
Blood Advances|April 14, 2023
Activity of luspatercept and ESAs combination for treatment of anemia in lower-risk myelodysplastic syndromesRami S Komrokji, Luis E Aguirre, Najla H Al Ali, et al.
Cancer|September 26, 2019
Internet-assisted cognitive behavioral intervention for targeted therapy-related fatigue in chronic myeloid leukemia: Results from a pilot randomized trialHeather S L Jim, Kelly A Hyland, Ashley M Nelson, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 5, 2017
The Treatment Landscape of Myelofibrosis Before and After Ruxolitinib ApprovalAndrew T Kuykendall, Chetasi Talati, Najla Al Ali, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2018
Initial Diagnostic Work-Up of Acute Leukemia: ASCO Clinical Practice Guideline Endorsement of the College of American Pathologists and American Society of Hematology GuidelineValérie de Haas, Nofisat Ismaila, Anjali Advani, et al.
Annals of Hematology|July 18, 2020
Favorable outcomes of acute leukemias of ambiguous lineage treated with hyperCVAD: a multi-center retrospective studyVu H Duong, Kebede H Begna, Sarah Kashanian, et al.
International Journal of Hematology|October 5, 2014
Increased genomic instability may contribute to the development of kinase domain mutations in chronic myeloid leukemiaKendra Sweet, Najla H Al Ali, Samir M Dalia, et al.
Haematologica|May 11, 2019
Comparisons of commonly used front-line regimens on survival outcomes in patients aged 70 years and older with acute myeloid leukemiaChetasi Talati, Varun C Dhulipala, Mar Tine Extermann, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 7, 2021
Correlates of fatigue severity in patients with chronic myeloid leukemia treated with targeted therapyLaura B Oswald, Kelly A Hyland, Sarah L Eisel, et al.
Annals of Hematology|December 1, 2017
Between a rux and a hard place: evaluating salvage treatment and outcomes in myelofibrosis after ruxolitinib discontinuationAndrew T Kuykendall, Savan Shah, Chetasi Talati, et al.
Leukemia|November 2, 2020
PTPN11 mutations are associated with poor outcomes across myeloid malignanciesDavid M Swoboda, Najla Al Ali, Onyee Chan, et al.
Pageof 9

Showing results (41-50 of 82) with videos related to

Sort By:
Pageof 9
Blood Advances|April 14, 2023
Activity of luspatercept and ESAs combination for treatment of anemia in lower-risk myelodysplastic syndromesRami S Komrokji, Luis E Aguirre, Najla H Al Ali, et al.
Cancer|September 26, 2019
Internet-assisted cognitive behavioral intervention for targeted therapy-related fatigue in chronic myeloid leukemia: Results from a pilot randomized trialHeather S L Jim, Kelly A Hyland, Ashley M Nelson, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 5, 2017
The Treatment Landscape of Myelofibrosis Before and After Ruxolitinib ApprovalAndrew T Kuykendall, Chetasi Talati, Najla Al Ali, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2018
Initial Diagnostic Work-Up of Acute Leukemia: ASCO Clinical Practice Guideline Endorsement of the College of American Pathologists and American Society of Hematology GuidelineValérie de Haas, Nofisat Ismaila, Anjali Advani, et al.
Annals of Hematology|July 18, 2020
Favorable outcomes of acute leukemias of ambiguous lineage treated with hyperCVAD: a multi-center retrospective studyVu H Duong, Kebede H Begna, Sarah Kashanian, et al.
International Journal of Hematology|October 5, 2014
Increased genomic instability may contribute to the development of kinase domain mutations in chronic myeloid leukemiaKendra Sweet, Najla H Al Ali, Samir M Dalia, et al.
Haematologica|May 11, 2019
Comparisons of commonly used front-line regimens on survival outcomes in patients aged 70 years and older with acute myeloid leukemiaChetasi Talati, Varun C Dhulipala, Mar Tine Extermann, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 7, 2021
Correlates of fatigue severity in patients with chronic myeloid leukemia treated with targeted therapyLaura B Oswald, Kelly A Hyland, Sarah L Eisel, et al.
Annals of Hematology|December 1, 2017
Between a rux and a hard place: evaluating salvage treatment and outcomes in myelofibrosis after ruxolitinib discontinuationAndrew T Kuykendall, Savan Shah, Chetasi Talati, et al.
Leukemia|November 2, 2020
PTPN11 mutations are associated with poor outcomes across myeloid malignanciesDavid M Swoboda, Najla Al Ali, Onyee Chan, et al.
Pageof 9